DNA-C

N/A

Report date: 2025/02/12 10:56:00

Base Information

Drug NameDNA-C
Drug Alias NameDNA-HIV-PT123 vaccineHIV DNA疫苗HIV clade C DNA vaccineHIV DNA vaccineDNA-C +[6] 
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsAcquired Immunodeficiency SyndromeHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUgandaSouth Africa +[5] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGeneartUniversity Of RegensburgEurovacc
China Registration ClassN/A

Develop Information

Active CompaniesEurovacc
Inactive CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsHIV Infections
Inactive IndicationsAcquired Immunodeficiency Syndrome

Other Information

ATC CodeN/A
Related LinksN/A